2025-03-12 11:12:15
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Mankind Pharma Ltd reports consolidated net profit of Rs. 453.76 crores in Q3 FY24
Posted On : 2024-02-01 00:39:18( TIMEZONE : IST )
Mankind Pharma Limited has reported Consolidated financial results for the period ended December 31, 2023.
Financial Results (Q3 FY2024) - QoQ Comparison
The company has reported total income of Rs. 2677.0915 crores during the period ended December 31, 2023 as compared to Rs. 2768.0774 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs. 453.76 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 501.0260 crores for the period ended September 30, 2023.
The company has reported EPS of Rs. 11.31 for the period ended December 31, 2023 as compared to Rs. 12.49 for the period ended September 30, 2023.
| Financials | Q3 FY2024 | Q2 FY2024 | % Change |
| Total Income | ₹ 2677.0915 crs | ₹2768.0774 crs |  -3.29% |
| Net Profit | ₹453.76 crs | ₹501.0260 crs | -9.43% |
| EPS | ₹11.31 | ₹12.49 | -9.45% |
Financial Results (Q3 FY2024) - YoY Comparison
The company has reported total income of Rs. 2677.0915 crores during the period ended December 31, 2023 as compared to Rs.2128.0737 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.453.76 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.284.1524 crores for the period ended December 31, 2022.
The company has reported EPS of Rs.11.31 for the period ended December 31, 2023 as compared to Rs.7.09 for the period ended December 31, 2022.
| Financials | Q3 FY2024 | Q3 FY2023 | % Change |
| Total Income | ₹ 2677.0915 crs | ₹2128.0737 crs |  25.80% |
| Net Profit | ₹453.76 crs | ₹284.1524 crs | 59.69% |
| EPS | ₹11.31 | ₹7.09 | 59.52% |
Financial Results (9 Months Ended FY2024) - YoY Comparison
The company has reported total income of Rs.8082.4053 crores during the 9 Months period ended December 31, 2023 as compared to Rs.6777.8216 crores during the 9 Months period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.1441.6582 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.996.4205 crores for the 9 Months period ended December 31, 2022.
The company has reported EPS of Rs.35.94 for the 9 Months period ended December 31, 2023 as compared to Rs.24.87 for the 9 Months period ended December 31, 2022.
| Financials | 9 Months Ended FY2024 | 9 Months Ended FY2023 | % Change |
| Total Income | ₹8082.4053 crs | ₹6777.8216 crs | 19.25% |
| Net Profit | ₹1441.6582 crs | ₹996.4205 crs | 44.68% |
| EPS | ₹35.94 | ₹24.87 | 44.51% |
Shares of Mankind Pharma Limited was last trading in BSE at Rs. 1999.55 as compared to the previous close of Rs. 2057.00. The total number of shares traded during the day was 18627 in over 3438 trades.
The stock hit an intraday high of Rs. 2082.10 and intraday low of 1980.00. The net turnover during the day was Rs. 37833815.00.
